| Revised international prognostic scoring system for myelodysplastic syndromes PL Greenberg, H Tuechler, J Schanz, G Sanz, G Garcia-Manero, F Solé, ... Blood, The Journal of the American Society of Hematology 120 (12), 2454-2465, 2012 | 3435 | 2012 |
| New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international … J Schanz, H Tüchler, F Solé, M Mallo, E Luno, J Cervera, I Granada, ... Journal of clinical oncology 30 (8), 820-829, 2012 | 846 | 2012 |
| Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma V Fernàndez, O Salamero, B Espinet, F Solé, C Royo, A Navarro, ... Cancer research 70 (4), 1408-1418, 2010 | 545 | 2010 |
| Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes E Bernard, Y Nannya, RP Hasserjian, SM Devlin, H Tuechler, ... Nature medicine 26 (10), 1549-1556, 2020 | 497 | 2020 |
| SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype A Mozos, C Royo, E Hartmann, D De Jong, C Baró, A Valera, K Fu, ... haematologica 94 (11), 1555, 2009 | 478 | 2009 |
| Molecular international prognostic scoring system for myelodysplastic syndromes E Bernard, H Tuechler, PL Greenberg, RP Hasserjian, JE Arango Ossa, ... NEJM evidence 1 (7), EVIDoa2200008, 2022 | 462 | 2022 |
| Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes Solé, Espinet, Sanz, Cervera, Calasanz, Luño, Prieto, Granada, ... British journal of haematology 108 (2), 346-356, 2000 | 390 | 2000 |
| Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria E Matutes, D Oscier, C Montalban, F Berger, E Callet-Bauchu, A Dogan, ... Leukemia 22 (3), 487-495, 2008 | 320 | 2008 |
| Cytogenetic risk stratification in chronic myelomonocytic leukemia E Such, J Cervera, D Costa, F Solé, T Vallespí, E Luño, R Collado, ... Haematologica 96 (3), 375, 2011 | 308 | 2011 |
| Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients C Besses, F Cervantes, A Pereira, L Florensa, F Sole, ... Leukemia 13 (2), 150-154, 1999 | 303 | 1999 |
| Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes F Sole, E Luno, C Sanzo, B Espinet, GF Sanz, J Cervera, MJ Calasanz, ... Haematologica 90 (9), 1168-1178, 2005 | 295 | 2005 |
| Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group M Salido, C Baró, D Oscier, K Stamatopoulos, J Dierlamm, E Matutes, ... Blood, The Journal of the American Society of Hematology 116 (9), 1479-1488, 2010 | 229 | 2010 |
| Guidance for laboratories performing molecular pathology for cancer patients IA Cree, Z Deans, MJL Ligtenberg, N Normanno, A Edsjö, E Rouleau, ... Journal of clinical pathology 67 (11), 923-931, 2014 | 224 | 2014 |
| Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations MJ Calasanz, JC Cigudosa, MD Odero, C Ferreira, MT Ardanaz, A Fraile, ... Genes, Chromosomes and Cancer 18 (2), 84-93, 1997 | 222 | 1997 |
| Analysis of the IgVH somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical … P Algara, MS Mateo, M Sanchez-Beato, M Mollejo, IC Navas, L Romero, ... Blood, The Journal of the American Society of Hematology 99 (4), 1299-1304, 2002 | 209 | 2002 |
| Role of casein kinase 1A1 in the biology and targeted therapy of del (5q) MDS RK Schneider, V Adema, D Heckl, M Järås, M Mallo, AM Lord, LP Chu, ... Cancer cell 26 (4), 509-520, 2014 | 207 | 2014 |
| Time-dependent changes in mortality and transformation risk in MDS M Pfeilstöcker, H Tuechler, G Sanz, J Schanz, G Garcia-Manero, F Solé, ... Blood, The Journal of the American Society of Hematology 128 (7), 902-910, 2016 | 187 | 2016 |
| Molecular heterogeneity in MCL defined by the use of specificVH genes and the frequency of somatic mutations FI Camacho, P Algara, A Rodrıguez, E Ruız-Ballesteros, M Mollejo, ... Blood, The Journal of the American Society of Hematology 101 (10), 4042-4046, 2003 | 173 | 2003 |
| Trisomy 12 in chronic lymphocytic leukemia: an interphase cytogenetic study AP Losada, M Wessman, M Tiainen, AH Hopman, HF Willard, F Sole, ... | 173 | 1991 |
| Classification and personalized prognostic assessment on the basis of clinical and genomic features in myelodysplastic syndromes M Bersanelli, E Travaglino, M Meggendorfer, T Matteuzzi, C Sala, ... Journal of Clinical Oncology 39 (11), 1223-1233, 2021 | 170 | 2021 |
Lurdes ZamoraCoordinadora de la Unitat de Biologia Molecular, Servei Laboratori Hematologia, Institut Català d’Oncologia - Institut Josep Carreras在 iconcologia.net 的电子邮件经过验证
